New Athira Pharma Drug Trial for Parkinson’s, with Dr. Arif Khan

December 13, 2021

Dr. Arif Khan at the Northwest Clinical Research Center talks about Parkinson’s disease and an exciting clinical study by Athira Pharma for the treatment of Parkinson’s Disease Dementia (PDD) and Dementia with Lewy Bodies. The medicine is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function. It’s a new approach, potentially…

Read More

Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family.

April 21, 2021

AFE has partnered with Athira Pharma for outreach on new clinical trials for ATH-1017, an investigational treatment for Alzheimer’s Disease. In this segment, Dr. David Greeley, MD, FAAN, founder of Northwest Neurological, focuses on the details of clinical trials and what they mean for you and your family. Northwest Neurological in Spokane, Washington provides medical services to patients with neurological concerns…

Read More